BSE: 532851 | NSE: INSECTICID | Pesticides & Agrochemicals | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that Insecticides (India) Ltd is a average quality company.
The key valuation ratios of Insecticides (India) Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Insecticides (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 17.6% | 12.4% | 15.6% | 19.7% | 20.7% | 14.3% | 13.7% | 16.1% | 9.8% | 13.2% | - |
| Value Creation Index ⓘ | 0.3 | -0.1 | 0.1 | 0.4 | 0.5 | 0.0 | 0.0 | 0.2 | -0.3 | -0.1 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 964 | 988 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 1,914 |
| Sales YoY Gr. | - | 2.5% | 0.6% | 8% | 11.2% | 14.2% | 4.2% | 5.9% | 19.8% | 9.2% | - |
| Adj EPS ⓘ | 19.3 | 12.7 | 17.8 | 27.5 | 40.5 | 29 | 31.4 | 36.1 | 23.9 | 33.4 | 45.1 |
| YoY Gr. | - | -33.9% | 40.1% | 54.1% | 47.3% | -28.5% | 8.6% | 14.7% | -33.7% | 39.6% | - |
| BVPS (₹) ⓘ | 101.4 | 131.5 | 149.9 | 176.6 | 213.3 | 235.6 | 264 | 293 | 309.4 | 341.6 | 383.4 |
| Adj Net Profit ⓘ | 55 | 39.5 | 55.3 | 85.2 | 126 | 89.8 | 97.4 | 107 | 70.8 | 98.8 | 131 |
| Cash Flow from Ops. ⓘ | -5.7 | 84.5 | 4 | 182 | -133 | 242 | 155 | 135 | -10.6 | 185 | - |
| Debt/CF from Ops. ⓘ | -56.1 | 2.4 | 59 | 0.6 | -2.3 | 0.8 | 0.6 | 0.4 | -15 | 0.5 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 8.2% | 10.5% | 11.5% | 9.2% | ||||
| Adj EPS ⓘ | 6.3% | -3.8% | 2% | 39.6% | ||||
| BVPSⓘ | 14.5% | 9.9% | 9% | 10.4% | ||||
| Share Price | 6.4% | 18.1% | 17.9% | 3.2% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 20.5 | 11.3 | 12.7 | 16.8 | 20.8 | 12.9 | 12.6 | 12.7 | 7.9 | 10.3 | 12.4 |
| Op. Profit Mgn % ⓘ | 11.5 | 9.3 | 11.2 | 13.9 | 16.1 | 11.8 | 10.8 | 11.4 | 7.4 | 8.3 | 10.3 |
| Net Profit Mgn % ⓘ | 5.7 | 4 | 5.6 | 7.9 | 10.5 | 6.6 | 6.9 | 7.1 | 3.9 | 5 | 6.9 |
| Debt to Equity ⓘ | 1.1 | 0.5 | 0.5 | 0.2 | 0.5 | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 | 0 |
| Working Cap Days ⓘ | 212 | 231 | 238 | 221 | 258 | 249 | 232 | 232 | 214 | 211 | 151 |
| Cash Conv. Cycle ⓘ | 95 | 106 | 119 | 101 | 144 | 122 | 116 | 109 | 111 | 100 | 74 |
Return on Equity has increased versus last 3 years average to 12.40%
Sales growth is growing at healthy rate in last 3 years 11.46%
Net Profit has been subdued in last 3 years 2.03%
Sales growth is not so good in last 4 quarters at -4.15%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 45.1 | 44.9 |
| TTM Sales (₹ Cr.) | 1,914 | 1,914 |
| BVPS (₹.) ⓘ | 383.4 | 384.1 |
| Reserves (₹ Cr.) ⓘ | 1,087 | 1,089 |
| P/BV ⓘ | 1.86 | 1.86 |
| PE ⓘ | 15.84 | 15.90 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 460.50 / 1084.65 |
| All Time Low / High (₹) | 11.76 / 1084.65 |
| Market Cap (₹ Cr.) | 2,077 |
| Equity (₹ Cr.) | 29.1 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 42.2 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 964 | 988 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 |
| Operating Expenses ⓘ | 853 | 897 | 883 | 925 | 1,006 | 1,207 | 1,268 | 1,334 | 1,679 | 1,803 |
| Manufacturing Costs | 93 | 92 | 129 | 130 | 163 | 144 | 170 | 188 | 218 | 257 |
| Material Costs | 584 | 609 | 670 | 694 | 726 | 937 | 974 | 1,007 | 1,275 | 1,336 |
| Employee Cost | 34 | 40 | 46 | 51 | 65 | 75 | 77 | 87 | 98 | 117 |
| Other Costs ⓘ | 142 | 156 | 39 | 50 | 52 | 52 | 47 | 52 | 88 | 93 |
| Operating Profit ⓘ | 111 | 91 | 111 | 148 | 187 | 156 | 152 | 170 | 122 | 163 |
| Operating Profit Margin (%) | 11.5% | 9.2% | 11.2% | 13.8% | 15.7% | 11.4% | 10.7% | 11.3% | 6.8% | 8.3% |
| Other Income ⓘ | 0 | 1 | 7 | 3 | 1 | 3 | 8 | 4 | 1 | 10 |
| Interest ⓘ | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 |
| Depreciation ⓘ | 14 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | -10 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 64 | 50 | 82 | 118 | 153 | 110 | 119 | 141 | 84 | 133 |
| Tax ⓘ | 9 | 11 | 23 | 34 | 31 | 24 | 26 | 34 | 21 | 30 |
| Profit After Tax | 55 | 39 | 59 | 84 | 122 | 86 | 93 | 107 | 63 | 103 |
| PAT Margin (%) | 5.7% | 4.0% | 6.0% | 7.8% | 10.3% | 6.3% | 6.6% | 7.1% | 3.5% | 5.2% |
| Adjusted EPS (₹) | 19.2 | 12.7 | 19.2 | 27.1 | 39.5 | 27.8 | 30.1 | 36.2 | 21.3 | 34.7 |
| Dividend Payout Ratio (%) | 6% | 11% | 7% | 5% | 3% | 14% | 4% | 6% | 14% | 9% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 291 | 409 | 465 | 548 | 661 | 730 | 818 | 867 | 916 | 1,011 |
| Share Capital ⓘ | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 |
| Reserves ⓘ | 279 | 388 | 444 | 527 | 641 | 710 | 798 | 847 | 886 | 982 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 295 | 180 | 221 | 105 | 296 | 185 | 94 | 47 | 157 | 72 |
| Long Term Debt | 54 | 28 | 15 | 8 | 1 | 2 | 2 | 2 | 2 | 29 |
| Short Term Debt | 241 | 152 | 206 | 97 | 295 | 183 | 92 | 46 | 155 | 43 |
| Trade Payables | 210 | 211 | 199 | 243 | 280 | 247 | 362 | 324 | 448 | 418 |
| Others Liabilities ⓘ | 125 | 137 | 111 | 129 | 150 | 153 | 181 | 191 | 194 | 242 |
| Total Liabilities ⓘ | 921 | 936 | 995 | 1,025 | 1,388 | 1,316 | 1,456 | 1,430 | 1,715 | 1,744 |
Fixed Assets | ||||||||||
| Gross Block | 238 | 242 | 200 | 264 | 292 | 314 | 337 | 370 | 402 | 447 |
| Accumulated Depreciation | 34 | 49 | 16 | 33 | 52 | 75 | 98 | 117 | 140 | 165 |
| Net Fixed Assetsⓘ | 205 | 194 | 185 | 232 | 240 | 239 | 239 | 253 | 262 | 282 |
| CWIP ⓘ | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 141 |
| Investmentsⓘ | 11 | 11 | 11 | 16 | 12 | 10 | 12 | 13 | 15 | 19 |
| Inventories | 391 | 351 | 426 | 407 | 705 | 519 | 661 | 630 | 862 | 806 |
| Trade Receivables | 167 | 208 | 212 | 235 | 244 | 320 | 255 | 289 | 296 | 297 |
| Cash Equivalents | 7 | 9 | 9 | 20 | 9 | 74 | 83 | 36 | 19 | 61 |
| Others Assetsⓘ | 103 | 113 | 95 | 99 | 158 | 114 | 148 | 117 | 137 | 138 |
| Total Assets ⓘ | 921 | 936 | 995 | 1,025 | 1,388 | 1,316 | 1,456 | 1,430 | 1,715 | 1,744 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | -6 | 85 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 185 |
| PBT ⓘ | 64 | 50 | 82 | 118 | 153 | 110 | 119 | 141 | 84 | 133 |
| Adjustment ⓘ | 38 | 37 | 38 | 32 | 38 | 48 | 30 | 36 | 38 | 39 |
| Changes in Working Capital ⓘ | -100 | 12 | -99 | 58 | -292 | 115 | 34 | -2 | -101 | 26 |
| Tax Paid ⓘ | -7 | -13 | -17 | -26 | -32 | -32 | -27 | -41 | -31 | -14 |
| Cash Flow From Investing Activity ⓘ | -33 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -87 | -44 |
| Capex | -33 | -19 | -14 | -28 | -37 | -28 | -48 | -67 | -86 | -44 |
| Net Investments | 0 | 0 | 0 | 2 | 0 | -6 | -70 | 76 | 0 | 0 |
| Others ⓘ | 0 | 0 | 0 | 0 | -12 | 10 | 5 | 1 | -1 | 0 |
| Cash Flow From Financing Activityⓘ | 36 | -63 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 |
| Net Proceeds from Shares ⓘ | 0 | 81 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | -24 | -13 | -7 | -6 | 1 | -1 | 0 | 27 |
| Interest Paid ⓘ | -24 | -21 | -21 | -16 | -14 | -25 | -7 | -7 | -13 | -11 |
| Dividend Paid ⓘ | -4 | -9 | 0 | -4 | -4 | -12 | -4 | 0 | -15 | -9 |
| Others ⓘ | 64 | -114 | 54 | -110 | 197 | -116 | -94 | -107 | 108 | -105 |
| Net Cash Flow ⓘ | -2 | 3 | 0 | 13 | -11 | 59 | -61 | 30 | -18 | 43 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 20.71 | 11.27 | 13.62 | 16.59 | 20.25 | 12.37 | 12.07 | 12.7 | 7.07 | 10.65 |
| ROCE (%) | 17.55 | 12.38 | 15.55 | 19.66 | 20.66 | 14.26 | 13.72 | 16.12 | 9.75 | 13.23 |
| Asset Turnover Ratio | 1.2 | 1.13 | 1.11 | 1.21 | 1.08 | 1.12 | 1.15 | 1.14 | 1.26 | 1.27 |
| PAT to CFO Conversion(x) | -0.11 | 2.18 | 0.07 | 2.17 | -1.09 | 2.81 | 1.67 | 1.26 | -0.17 | 1.8 | Working Capital Days |
| Receivable Days | 52 | 65 | 71 | 67 | 67 | 68 | 66 | 60 | 54 | 49 |
| Inventory Days | 124 | 129 | 132 | 125 | 155 | 148 | 136 | 143 | 137 | 139 |
| Payable Days | 129 | 126 | 112 | 116 | 132 | 103 | 114 | 124 | 111 | 118 |
Insecticides (IIL) Company was originally incorporated as Insecticides (India) Private Limited vide on December 18, 1996 under the Companies Act 1956 with the Registrar of Companies NCT of Delhi & Haryana. The company was converted into Public Limited Company on October 29, 2001,
Insecticides (India) has spearheaded the endeavor to bring home world-class quality new generation products through latest technological developments. IIL has entered into technical collaboration with global giants AMVAC, USA for THIMET, which is India's most popular generic pesticide. Thimet, being the first choice of Indian farmers has helped the company in further strengthening its base at the grass root level.
Lap after lap, in this marathon success story, they have weakened the competition to become India’s leading agro-chemical and pesticides manufacturer. The company will soon be starting pesticide-synthesis at Bhiwadi plant. This will help the company in bringing out new products at more competitive prices. Its vision and efforts have ushered in a new era of success and helped IIL to emerge as a formidable player in the Indian agro-chemicals sector. IIL has established a dedicated R&D Center, which is recognized by Department of Scientific & Industrial Research, Ministry of Science and Technology. It focuses on manufacturing high value added, complex new molecules for introduction in the generic market. Though immense efforts have been made, they have far to go. At IIL R&D, they approach each challenge armed with their knowledge of Agri-science & motivated by their commitment to increase crop yield per acre of land.They have taken big steps towards capitalizing on the revolution in crop protection, which is an integral part of holistic crop management.
IIL R&D centre has augmented its infrastructure with sophisticated instruments like HPLC, GLC, AAS, UV and Infrared Spectrophotometer that are used for standardization of manufacturing processes. For production of a wide range of agro-chemicals and pesticides, IIL has set production units at Rajasthan and J&K . These state-of-the-art production facilities offer an integrated environment to ensure optimum performance levels and facilitate production of high quality liquid, granule and powder formulations.
Product range of the company includes:
Crop:
Urban pest:
Achievements/ recognition:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
